Clarus Therapeutics Up 49%_老虎社区_美港股上老虎

Clarus Therapeutics Up 49%

Dow Jones2022-04-21

By Josh Beckerman

Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16.

On Tuesday, Clarus shares rose 22% after the company said it would present new data for Jatenzo, a testosterone capsule, on Saturday at the Androgen Society's annual meeting. Two abstracts will be presented, including one that discusses a comparison with AndroGel 1%.

Write to Josh Beckerman at josh.beckerman@wsj.com

$(END)$ Dow Jones Newswires

April 20, 2022 14:46 ET (18:46 GMT)

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Jo_9642
·2022-04-22
Nice
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2229920369?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2022-04-21 02:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2229920369","market":"us","top_or_hot":-1,"title":"Clarus Therapeutics Up 49%","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n   By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n   Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16. \n</p>\n<p>\n   On Tuesday, Clarus shares rose 22% after the company said it would present new data for Jatenzo, a testosterone capsule, on Saturday at the Androgen Society's annual meeting. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> abstracts will be presented, including <a href=\"https://laohu8.com/S/AONE.U\">one</a> that discusses a comparison with AndroGel 1%. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  April 20, 2022 14:46 ET (18:46 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clarus Therapeutics Up 49%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClarus Therapeutics Up 49%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-21 02:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Josh Beckerman \n\n\n \n\n\n   Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16. \n\n\n   On Tuesday, Clarus shares rose 22% after the company said it would present new data for ...</p>\n\n<a href=\"http://dowjonesnews.com/newdjn/logon.aspx?AL=N\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4209","symbol_name":"餐馆","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2229920369","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2229920369","pubTimestamp":1650480360,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"By Josh Beckerman \n\n\n \n\n\n   Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4209":"餐馆","BK4007":"制药","BK4183":"个人用品","FWRG":"First Watch Restaurant Group, Inc.","OLPX":"Olaplex Holdings, Inc.","BK4167":"医疗保健技术","BK4191":"家用电器","CRCT":"Cricut, Inc.","HCTI":"Healthcare Triangle, Inc.","TERN":"Terns Pharmaceuticals, Inc.","CRXT":"Clarus Therapeutics Holdings, Inc.","BK4539":"次新股"},"translate_title":"Clarus Therapeutics上涨49%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"END":1,"ALVU":0.9,"CRCT":0.9,"CRXT":0.9,"FWRG":0.9,"HCTI":0.9,"OLPX":0.9,"TERN":0.9},"content_text":"By Josh Beckerman \n\n\n \n\n\n   Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16. \n\n\n   On Tuesday, Clarus shares rose 22% after the company said it would present new data for Jatenzo, a testosterone capsule, on Saturday at the Androgen Society's annual meeting. Two abstracts will be presented, including one that discusses a comparison with AndroGel 1%. \n\n\n \n\n\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  April 20, 2022 14:46 ET (18:46 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":611766404,"gmtCreate":1650631678944,"gmtModify":1650631679004,"author":{"id":"3581644013751039","authorId":"3581644013751039","authorIdStr":"3581644013751039","name":"Jo_9642","avatar":"https://static.tigerbbs.com/30f7bb0eea2092bdc8a724d0ad15c302","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/611766404","repostId":2229920369,"repostType":2,"repost":{"id":"2229920369","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1650480360,"share":"https://www.laohu8.com/m/news/2229920369?lang=&edition=full","pubTime":"2022-04-21 02:46","market":"us","language":"en","title":"Clarus Therapeutics Up 49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2229920369","media":"Dow Jones","summary":"By Josh Beckerman \n\n\n \n\n\n   Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16. ","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n   By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n   Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16. \n</p>\n<p>\n   On Tuesday, Clarus shares rose 22% after the company said it would present new data for Jatenzo, a testosterone capsule, on Saturday at the Androgen Society's annual meeting. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> abstracts will be presented, including <a href=\"https://laohu8.com/S/AONE.U\">one</a> that discusses a comparison with AndroGel 1%. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  April 20, 2022 14:46 ET (18:46 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clarus Therapeutics Up 49%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClarus Therapeutics Up 49%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-04-21 02:46</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n   By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n   Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16. \n</p>\n<p>\n   On Tuesday, Clarus shares rose 22% after the company said it would present new data for Jatenzo, a testosterone capsule, on Saturday at the Androgen Society's annual meeting. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> abstracts will be presented, including <a href=\"https://laohu8.com/S/AONE.U\">one</a> that discusses a comparison with AndroGel 1%. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  April 20, 2022 14:46 ET (18:46 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TERN":"Terns Pharmaceuticals, Inc.","BK4183":"个人用品","FWRG":"First Watch Restaurant Group, Inc.","BK4209":"餐馆","BK4167":"医疗保健技术","BK4191":"家用电器","CRXT":"Clarus Therapeutics Holdings, Inc.","CRCT":"Cricut, Inc.","BK4007":"制药","BK4539":"次新股","OLPX":"Olaplex Holdings, Inc.","HCTI":"Healthcare Triangle, Inc."},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2229920369","content_text":"By Josh Beckerman \n\n\n \n\n\n   Clarus Therapeutics Holdings Inc. shares were recently up 49% to $2.16. \n\n\n   On Tuesday, Clarus shares rose 22% after the company said it would present new data for Jatenzo, a testosterone capsule, on Saturday at the Androgen Society's annual meeting. Two abstracts will be presented, including one that discusses a comparison with AndroGel 1%. \n\n\n \n\n\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  April 20, 2022 14:46 ET (18:46 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}